Network study, only half of Placenta Accreta Spectrum (PAS) cases were suspected before delivery and their outcomes were poorer than unanticipated cases, possibly because antenatally suspected cases were of greater severity (Bailit et al, 2015). We sought to compare the outcomes of expected (ePAS) vs unexpected PAS (uPAS) in a large U.S. center. STUDY DESIGN: Retrospective cohort of all histology-proven PAS deliveries in an academic referral center between January 1, 2000 and June 30, 2018; Patients only diagnosed at delivery were cases (uPAS), those antentally diagnosed were controls (ePAS.). Demographics, clinical characteristics and outcomes were analyzed using appropriate statistical methods (Table) . Primary outcomes were: estimated blood loss (EBL) > 2L, and need for red blood cell (RBC) transfusion. Since we previously (2010) demonstrated our Multidisciplinary Approach (Multi-D) to improve maternal outcomes in our cohort, we adjusted for Multi-D in the analysis of the association between the primary outcomes and unexpected PAS (Logistic Regression). RESULTS: There were 72/268 (26.9%) patients in the uPAS group. Table 1 shows the characteristics and outcomes. Placenta previa and previous cesarean delivery (CD) were more common in the ePAS group. The median number of prior CD's was 2 [0-6] in ePAS and 1 [0][1][2][3][4][5] ajog.org
shows the characteristics and outcomes. Placenta previa and previous cesarean delivery (CD) were more common in the ePAS group. The median number of prior CD's was 2 [0-6] in ePAS and 1 [0] [1] [2] [3] [4] [5] in the uPAS group (P<0.001). There was a higher proportion of increta/ percreta in ePAS vs. uPAS [128 (65.3%) (TBS) . In TBS, women with diamniotic twins with a cephalic presenting twin between 32 0/7 and 38 6/7 weeks gestation were randomized to planned vaginal or cesarean delivery. In this secondary analysis, women attempting vaginal birth of twins were analyzed. We performed a retrospective case-control study, according to success (vaginal delivery of both twins) or failure (cesarean of one or both twins) of twin vaginal delivery. Maternal and fetal characteristics prior to labor were evaluated in order to identify variables significantly associated with success or failure of twin vaginal birth. Logistic regression was used to create a prediction model that was validated against a training set. RESULTS: 1124 patients attempting a trial of vaginal delivery of twins were analyzed. 783 (70%) successfully delivered vaginally, and 341 (30%)had a cesarean of one or both twins. Pre-labor characteristics significantly associated with delivery route were: maternal age, parity, history of prior cesarean delivery, and presentation of the second twin. Using these characteristics, a predictive model was developed. An ROC curve was developed to assess accuracy with an AUC of 0.6 (Figure 1 RESULTS: Forty-five fetal samples were compared using CBC and HemoCue. Fifteen cordocentesis procedures were performed on 10 patients during the study period. The mean gestational age for the cordocentesis was 27.7 (range 19-36 weeks). Use of HemoCue was associated with a significantly shorter time to yield a fetal hemoglobin result, compared to traditional CBC (1.6 vs 5.6 minutes, p¼.0001), as seen in Figure 1 . 
OBJECTIVE: Prophylactic antibiotics are indicated in Preterm Premature
Rupture of Membranes (PROM) to prolong latency and to reduce the risk of both neonatal and maternal infections. Macrolides are usually given with penicillin based on their activity against the major pelvic pathogens. We aimed to compare outcomes between two different macrolides: Roxithromycin which is given twice a day for a week and Azithromycin given as a single dose and therefore more convenient STUDY DESIGN: Inclusion criteria were: a singletone pregnancy, 24-34 weeks of gestation, preterm PROM. All were treated with penicillin and macrolides: Roxithromycin between July 2005 and May 2016, and Azithromycin between May 2016 and May 2018 based on local protocol changes during those two periods of time. The primary outcome was the length of latency period, defined as time from first antibiotic dose to 34+0 weeks or spontaneous or indicated delivery prior to 34+0 weeks. Secondary outcomes were rates of chorioamnionitis, mode of delivery, birth weight and Apgar scores RESULTS: Of 207 women who met inclusion criteria, 173 received Penicillin and Roxithromycin and 34 received Penicillin and
